v3.26.1
NOTE 15 – SEGMENT INFORMATION (Tables)
9 Months Ended
May 31, 2026
Segment Reporting [Abstract]  
NOTE 14 - SEGMENT INFORMATION - Financial Information by Segment

 

                                               
   IP Segment  Cinema Segment  Total
   Nine months ended  Nine months ended  Nine months ended
   May 31, 2026  May 31, 2025  May 31, 2026  May 31, 2025  May 31, 2026  May 31, 2025
Revenue  $6,991,673   $3,308,128   $176,824   $221,954   $7,168,497   $3,530,082 
Costs of copyrights sold         1,510,921                      1,510,921 
Theatre operating costs               85,681    118,598    85,681    118,598 
Depreciation and Amortization   3,468,840    850,996                3,468,840    850,996 
Interest expense   209,964    40,041                209,964    40,041 
Segment assets   10,006,176    6,368,028    122,293    109,704    10,128,469    6,477,732 
Segment (loss) income  $(1,578,386)  $186,354   $(150,433)  $(146,703)  $(1,728,819)  $39,651 

 

The following table presents summarized financial information by reportable segment for the three months ended May 31, 2026 and 2025, respectively. 

                                                 
   IP Segment  Cinema Segment  Total
   Three months ended  Three months ended  Three months ended
   May 31, 2026  May 31, 2025  May 31, 2026  May 31, 2025  May 31, 2026  May 31, 2025
Revenue  $1,438,820   $1,786,100   $63,019   $59,089   $1,501,839   $1,845,189 
Costs of copyrights sold         780,871                      780,871 
Theatre operating costs               35,849    25,995    35,849    25,995 
Depreciation and Amortization   1,445,886    595,278                1,445,886    595,278 
Interest expense   147,863    36,468                147,863    36,468 
Segment assets   10,006,176    6,368,028    122,293    109,704    10,128,469    6,477,732 
Segment (loss) income  $(4,276,593)  $(75,106)  $(52,404)  $(50,138)  $(4,328,997)  $(125,244)

 

 

AI ERA CORP. (FORMERLY KNOWN AS AB INTERNATIONAL GROUP CORP.) 

NOTES TO CONSOLIDATED FINANCIAL STTEMENTS

(Unaudited)